title: Update on sentinel lymph node biopsy in gynecologic cancers.
abstract: The sentinel lymph node biopsy (SLNB) holds the promise of more accurate staging of the primary tumor and fewer wound complications and lymphedema than associated with lymphadenectomy. Regional lymphadenectomy may no longer be a requirement in SLNB-negative patients if the SLN procedure is adequately validated in prospective clinical trials for gynecologic malignancies.
authors.affiliation: MD Anderson Cancer Center, Houston, TX, USA. clevenba@mdanderson.org
authors.forename: Charles
authors.initials: C
authors.lastname: Levenback
mesh_terms: D005260:Female; D005833:Genital Neoplasms, Female / Q000473:pathology*; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D009367:Neoplasm Staging; D021701:Sentinel Lymph Node Biopsy / Q000379:methods*